Co-regulation and epigenetic dysregulation in schizophrenia and bipolar disorder

Patho-Epigenetics of Disease

Volumn 9781461433453, Issue , 2012, Pages 281-347

  Zelena, Dóra ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84949175995     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-3345-3_10     Document Type: Chapter

References (387)

1. Abdolmaleky, H. M., Cheng, K. H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., Smith, C. L., Shafa, R., Aeali, B., Carnevale, J., Pan, H., Papageorgis, P., Ponte, J. F., Sivaraman, V., Tsuang, M. T. & Thiagalingam, S. (2006). Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 15, 3132-3145.
2. Abdolmaleky, H. M., Cheng, K. H., Russo, A., Smith, C. L., Faraone, S. V., Wilcox, M., Shafa, R., Glatt, S. J., Nguyen, G., Ponte, J. F., Thiagalingam, S. & Tsuang, M. T. (2005). Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 134B, 60-66.
3. Abdolmaleky, H. M., Smith, C. L., Faraone, S. V., Shafa, R., Stone, W., Glatt, S. J. & Tsuang, M. T. (2004). Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation. Am J Med Genet B Neuropsychiatr Genet 127B, 51-59.
4. Abdolmaleky, H. M., Zhou, J. R., Thiagalingam, S. & Smith, C. L. (2008). Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics. Pharmacogenomics 9, 1809-1823.
5. Abel, T. & Zukin, R. S. (2008). Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 8, 57-64.
6. Acharya, M. R., Sparreboom, A., Venitz, J. & Figg, W. D. (2005). Rational development of histone deacetylase inhibitors as anticancer agents: a review. Mol Pharmacol 68, 917-932.
7. Addington, J., Cadenhead, K. S., Cannon, T. D., Cornblatt, B., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M., Walker, E. F., Woods, S. W. & Heinssen, R. (2007). North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull 33, 665-672.
8. Aid, T., Kazantseva, A., Piirsoo, M., Palm, K. & Timmusk, T. (2007). Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85, 525-535.
9. Akbarian, S. (2010). Epigenetics of schizophrenia. Curr Top Behav Neurosci 4, 611-628.
10. Akbarian, S. & Huang, H. S. (2006). Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 52, 293-304.
11. Akbarian, S. & Huang, H. S. (2009). Epigenetic regulation in human brain-focus on histone lysine methylation. Biol Psychiatry 65, 198-203.
12. Akbarian, S., Kim, J. J., Potkin, S. G., Hagman, J. O., Tafazzoli, A., Bunney, W. E., Jr. & Jones, E. G. (1995). Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52, 258-266.
13. Akbarian, S., Ruehl, M. G., Bliven, E., Luiz, L. A., Peranelli, A. C., Baker, S. P., Roberts, R. C., Bunney, W. E., Jr., Conley, R. C., Jones, E. G., Tamminga, C. A. & Guo, Y. (2005). Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 62, 829-840.
14. Allan, A. M., Liang, X., Luo, Y., Pak, C., Li, X., Szulwach, K. E., Chen, D., Jin, P. & Zhao, X. (2008). The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits. Hum Mol Genet 17, 2047-2057.
15. Alt, S. R., Turner, J. D., Klok, M. D., Meijer, O. C., Lakke, E. A., Derijk, R. H. & Muller, C. P. (2010). Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology 35, 544-556.
16. Amminger, G. P., Leicester, S., Yung, A. R., Phillips, L. J., Berger, G. E., Francey, S. M., Yuen, H. P. & McGorry, P. D. (2006). Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophr Res 84, 67-76.
17. Angelucci, F., Brene, S. & Mathe, A. A. (2005). BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 10, 345-352.
18. Anton, E. S., Ghashghaei, H. T., Weber, J. L., McCann, C., Fischer, T. M., Cheung, I. D., Gassmann, M., Messing, A., Klein, R., Schwab, M. H., Lloyd, K. C. & Lai, C. (2004). Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci 7, 1319-1328.
19. Antun, F. T., Burnett, G. B., Cooper, A. J., Daly, R. J., Smythies, J. R. & Zealley, A. K. (1971). The effects of L-methionine (without MAOI) in schizophrenia. J Psychiatr Res 8, 63-71.
20. Assimacopoulos, S., Grove, E. A. & Ragsdale, C. W. (2003). Identification of a Pax6-dependent epidermal growth factor family signaling source at the lateral edge of the embryonic cerebral cortex. J Neurosci 23, 6399-6403.
21. Aston, C., Jiang, L. & Sokolov, B. P. (2004). Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77, 858-866.
22. Aston, C., Jiang, L. & Sokolov, B. P. (2005). Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 10, 309-322.
23. Babak, T., Zhang, W., Morris, Q., Blencowe, B. J. & Hughes, T. R. (2004). Probing microRNAs with microarrays: tissue specificity and functional inference. RNA 10, 1813-1819.
24. Balasubramanian, S., Verner, E. & Buggy, J. J. (2009). Isoform-specific histone deacetylase inhibitors: the next step? Cancer Lett 280, 211-221.
25. Balciuniene, J., Feng, N., Iyadurai, K., Hirsch, B., Charnas, L., Bill, B. R., Easterday, M. C., Staaf, J., Oseth, L., Czapansky-Beilman, D., Avramopoulos, D., Thomas, G. H., Borg, A., Valle, D., Schimmenti, L. A. & Selleck, S. B. (2007). Recurrent 10q22-q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalities. Am J Hum Genet 80, 938-947.
26. Barratt, M. J., Hazzalin, C. A., Cano, E. & Mahadevan, L. C. (1994). Mitogen-stimulated phosphorylation of histone H3 is targeted to a small hyperacetylation-sensitive fraction. Proc Natl Acad Sci U S A 91, 4781-4785.
27. Ben Shachar, D. & Laifenfeld, D. (2004). Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol 59, 273-296.
28. Benes, F. M. & Berretta, S. (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25, 1-27.
29. Benes, F. M., Lim, B., Matzilevich, D., Walsh, J. P., Subburaju, S. & Minns, M. (2007). Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci U S A 104, 10164-10169.
30. Benzel, I., Bansal, A., Browning, B. L., Galwey, N. W., Maycox, P. R., McGinnis, R., Smart, D., St Clair, D., Yates, P. & Purvis, I. (2007). Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav Brain Funct 3:31.
31. Berlet, H. H., Matsumoto, K., Pscheidt, G. R., Spaide, J., Bull, C. & Himwich, H. E. (1965). Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor. Arch Gen Psychiatry 13, 521-531.
32. Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., Jaenisch, R., Wagschal, A., Feil, R., Schreiber, S. L. & Lander, E. S. (2006). A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326.
33. Berton, O., McClung, C. A., Dileone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., Monteggia, L. M., Self, D. W. & Nestler, E. J. (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311, 864-868.
34. Bestelmeyer, P. E., Phillips, L. H., Crombie, C., Benson, P. & St Clair, D. (2009). The P300 as a possible endophenotype for schizophrenia and bipolar disorder: Evidence from twin and patient studies. Psychiatry Res 169, 212-219.
35. Beveridge, N. J., Tooney, P. A., Carroll, A. P., Gardiner, E., Bowden, N., Scott, R. J., Tran, N., Dedova, I. & Cairns, M. J. (2008). Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 17, 1156-1168.
36. Bicker, S. & Schratt, G. (2008). microRNAs: tiny regulators of synapse function in development and disease. J Cell Mol Med 12, 1466-1476.
37. Bilang-Bleuel, A., Ulbricht, S., Chandramohan, Y., De Carli, S., Droste, S. K. & Reul, J. M. (2005). Psychological stress increases histone H3 phosphorylation in adult dentate gyrus granule neurons: involvement in a glucocorticoid receptor-dependent behavioural response. Eur J Neurosci 22, 1691-1700.
38. Biliya, S. & Bulla, L. A., Jr. (2010). Genomic imprinting: the influence of differential methylation in the two sexes. Exp Biol Med (Maywood) 235, 139-147.
39. Biniszkiewicz, D., Gribnau, J., Ramsahoye, B., Gaudet, F., Eggan, K., Humpherys, D., Mastrangelo, M. A., Jun, Z., Walter, J. & Jaenisch, R. (2002). Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol Cell Biol 22, 2124-2135.
40. Bolden, J. E., Peart, M. J. & Johnstone, R. W. (2006). Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5, 769-784.
41. Bondy, B. (2011). Genetics in psychiatry: are the promises met? World J Biol Psychiatry 12, 81-88.
42. Borrelli, E., Nestler, E. J., Allis, C. D. & Sassone-Corsi, P. (2008). Decoding the epigenetic language of neuronal plasticity. Neuron 60, 961-974.
43. Bossong, M. G. & Niesink, R. J. (2010). Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol 92, 370-385.
44. Bradley, A. J. & Dinan, T. G. (2010). A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol 24, 91-118.
45. Branchi, I., Francia, N. & Alleva, E. (2004). Epigenetic control of neurobehavioural plasticity: the role of neurotrophins. Behav Pharmacol 15, 353-362.
46. Brandon, N. J., Millar, J. K., Korth, C., Sive, H., Singh, K. K. & Sawa, A. (2009). Understanding the role of DISC1 in psychiatric disease and during normal development. J Neurosci 29, 12768-12775.
47. Bray, N. J., Buckland, P. R., Hall, H., Owen, M. J. & O'Donovan, M. C. (2004). The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain. Mol Psychiatry 9, 109-114.
48. Broide, R. S., Redwine, J. M., Aftahi, N., Young, W., Bloom, F. E. & Winrow, C. J. (2007). Distribution of histone deacetylases 1-11 in the rat brain. J Mol Neurosci 31, 47-58.
49. Brown, A. S., Bottiglieri, T., Schaefer, C. A., Quesenberry, C. P., Jr., Liu, L., Bresnahan, M. & Susser, E. S. (2007). Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch Gen Psychiatry 64, 31-39.
50. Brown, G. G. & Thompson, W. K. (2010). Functional brain imaging in schizophrenia: selected results and methods. Curr Top Behav Neurosci 4, 181-214.
51. Bruneau, E. G., McCullumsmith, R. E., Haroutunian, V., Davis, K. L. & Meador-Woodruff, J. H. (2005). Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia. Schizophr Res 75, 27-34.
52. Brunet-Gouet, E. & Decety, J. (2006). Social brain dysfunctions in schizophrenia: a review of neuroimaging studies. Psychiatry Res 148, 75-92.
53. Buiting, K. (2010). Prader-Willi syndrome and Angelman syndrome. Am J Med Genet C Semin Med Genet 154C, 365-376.
54. Bunney, W. E., Bunney, B. G., Vawter, M. P., Tomita, H., Li, J., Evans, S. J., Choudary, P. V., Myers, R. M., Jones, E. G., Watson, S. J. & Akil, H. (2003). Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry 160, 657-666.
55. Burmeister, M., McInnis, M. G. & Zollner, S. (2008). Psychiatric genetics: progress amid controversy. Nat Rev Genet 9, 527-540.
56. Burnett, C., Valentini, S., Cabreiro, F., Goss, M., Somogyvari, M., Piper, M. D., Hoddinott, M., Sutphin, G. L., Leko, V., McElwee, J. J., Vazquez-Manrique, R. P., Orfila, A. M., Ackerman, D., Au, C., Vinti, G., Riesen, M., Howard, K., Neri, C., Bedalov, A., Kaeberlein, M., Soti, C., Partridge, L. & Gems, D. (2011). Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477, 482-485.
57. Carteron, C., Ferrer-Montiel, A. & Cabedo, H. (2006). Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival. J Cell Sci 119, 898-909.
58. Casey, D. E., Daniel, D. G., Tamminga, C., Kane, J. M., Tran-Johnson, T., Wozniak, P., Abi-Saab, W., Baker, J., Redden, L., Greco, N. & Saltarelli, M. (2009). Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia. Neuropsychopharmacology 34, 1330-1338.
59. Casey, D. E., Daniel, D. G., Wassef, A. A., Tracy, K. A., Wozniak, P. & Sommerville, K. W. (2003). Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology 28, 182-192.
60. Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A. & Poulton, R. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389.
61. Cavigelli, S. A. & McClintock, M. K. (2003). Fear of novelty in infant rats predicts adult corticosterone dynamics and an early death. Proc Natl Acad Sci U S A 100, 16131-16136.
62. Cedar, H. & Bergman, Y. (2009). Linking DNA methylation and histone modi fication: patterns and paradigms. Nat Rev Genet 10, 295-304.
63. Ceskova, E., Kasparek, T., Zourkova, A. & Prikryl, R. (2006). Dexamethasone suppression test in first-episode schizophrenia. Neuro Endocrinol Lett 27, 433-437.
64. Champagne, F. A., Francis, D. D., Mar, A. & Meaney, M. J. (2003). Variations in maternal care in the rat as a mediating influence for the effects of environment on development. Physiol Behav 79, 359-371.
65. Chandramohan, Y., Droste, S. K., Arthur, J. S. & Reul, J. M. (2008). The forced swimminginduced behavioural immobility response involves histone H3 phospho-acetylation and c-Fos induction in dentate gyrus granule neurons via activation of the N-methyl-D-aspartate/extracellular signal-regulated kinase/mitogen- and stress-activated kinase signalling pathway. Eur J Neurosci 27, 2701-2713.
66. Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., Egan, M. F., Kleinman, J. E. & Weinberger, D. R. (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75, 807-821.
67. Chen, P. L., Avramopoulos, D., Lasseter, V. K., McGrath, J. A., Fallin, M. D., Liang, K. Y., Nestadt, G., Feng, N., Steel, G., Cutting, A. S., Wolyniec, P., Pulver, A. E. & Valle, D. (2009). Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia. Am J Hum Genet 84, 21-34.
68. Chen, Y., Sharma, R. P., Costa, R. H., Costa, E. & Grayson, D. R. (2002). On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res 30, 2930-2939.
69. Cheng, L. C., Pastrana, E., Tavazoie, M. & Doetsch, F. (2009). miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 12, 399-408.
70. Cheung, P., Tanner, K. G., Cheung, W. L., Sassone-Corsi, P., Denu, J. M. & Allis, C. D. (2000). Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell 5, 905-915.
71. Chua, Y. L., Ito, Y., Pole, J. C., Newman, S., Chin, S. F., Stein, R. C., Ellis, I. O., Caldas, C., O'Hare, M. J., Murrell, A. & Edwards, P. A. (2009). The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene. Oncogene 28, 4041-4052.
72. Chuang, D. M., Leng, Y., Marinova, Z., Kim, H. J. & Chiu, C. T. (2009). Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32, 591-601.
73. Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J. & Millar, J. K. (2008). The DISC locus in psychiatric illness. Mol Psychiatry 13, 36-64.
74. Citrome, L. (2009). Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence? Expert Rev Neurother 9, 55-71.
75. Cohen, S., Zhou, Z. & Greenberg, M. E. (2008). Medicine. Activating a repressor. Science 320, 1172-1173.
76. Collins, A., Hill, L. E., Chandramohan, Y., Whitcomb, D., Droste, S. K. & Reul, J. M. (2009). Exercise improves cognitive responses to psychological stress through enhancement of epigenetic mechanisms and gene expression in the dentate gyrus. PLoS ONE 4, e4330.
77. Colvis, C. M., Pollock, J. D., Goodman, R. H., Impey, S., Dunn, J., Mandel, G., Champagne, F. A., Mayford, M., Korzus, E., Kumar, A., Renthal, W., Theobald, D. E. & Nestler, E. J. (2005). Epigenetic mechanisms and gene networks in the nervous system. J Neurosci 25, 10379-10389.
78. Connor, C. M. & Akbarian, S. (2008). DNA methylation changes in schizophrenia and bipolar disorder. Epigenetics 3, 55-58.
79. Cooney, C. A., Dave, A. A. & Wolff, G. L. (2002). Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 132, 2393S-2400S.
80. Costa, E., Chen, Y., Davis, J., Dong, E., Noh, J. S., Tremolizzo, L., Veldic, M., Grayson, D. R. & Guidotti, A. (2002). REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. Mol Interv 2, 47-57.
81. Costa, E., Chen, Y., Dong, E., Grayson, D. R., Kundakovic, M., Maloku, E., Ruzicka, W., Satta, R., Veldic, M., Zhubi, A. & Guidotti, A. (2009). GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability. Expert Rev Neurother 9, 87-98.
82. Costa, E., Dong, E., Grayson, D. R., Guidotti, A., Ruzicka, W. & Veldic, M. (2007). Reviewing the role of DNA (cytosine-5) methyltransferase overexpression in the cortical GABAergic dysfunction associated with psychosis vulnerability. Epigenetics 2, 29-36.
83. Cotter, D. & Pariante, C. M. (2002). Stress and the progression of the developmental hypothesis of schizophrenia. Br J Psychiatry 181, 363-365.
84. Couve, A., Restituito, S., Brandon, J. M., Charles, K. J., Bawagan, H., Freeman, K. B., Pangalos, M. N., Calver, A. R. & Moss, S. J. (2004). Marlin-1, a novel RNA-binding protein associates with GABA receptors. J Biol Chem 279, 13934-13943.
85. Covic, M., Karaca, E. & Lie, D. C. (2010). Epigenetic regulation of neurogenesis in the adult hippocampus. Heredity 105, 122-134.
86. Covington, H. E., Maze, I., LaPlant, Q. C., Vialou, V. F., Ohnishi, Y. N., Berton, O., Fass, D. M., Renthal, W., Rush, A. J., III, Wu, E. Y., Ghose, S., Krishnan, V., Russo, S. J., Tamminga, C., Haggarty, S. J. & Nestler, E. J. (2009). Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29, 11451-11460.
87. Coyle, J. T. (2004). The GABA-glutamate connection in schizophrenia: which is the proximate cause? Biochem Pharmacol 68, 1507-1514.
88. Craddock, N., O'Donovan, M. C. & Owen, M. J. (2006). Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 32, 9-16.
89. Crosio, C., Cermakian, N., Allis, C. D. & Sassone-Corsi, P. (2000). Light induces chromatin modi fication in cells of the mammalian circadian clock. Nat Neurosci 3, 1241-1247.
90. Crosio, C., Heitz, E., Allis, C. D., Borrelli, E. & Sassone-Corsi, P. (2003). Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modi fications and early gene expression in hippocampal neurons. J Cell Sci 116, 4905-4914.
91. Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R. & Feinberg, A. P. (2003). Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299, 1753-1755.
92. Daban, C., Vieta, E., Mackin, P. & Young, A. H. (2005). Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin North Am 28, 469-480.
93. Daskalakis, Z. J., Fitzgerald, P. B. & Christensen, B. K. (2007). The role of cortical inhibition in the pathophysiology and treatment of schizophrenia. Brain Res Rev 56, 427-442.
94. De Boer, P., Ramos, L., De Vries, M. & Gochhait, S. (2010). Memoirs of an insult: sperm as a possible source of transgenerational epimutations and genetic instability. Mol Hum Reprod 16, 48-56.
95. De Kloet, E. R., Derijk, R. H. & Meijer, O. C. (2007). Therapy Insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression? Nat Clin Pract Endocrinol Metab 3, 168-179.
96. De Luca, V., Likhodi, O., Kennedy, J. L. & Wong, A. H. (2007). Parent-of-origin effect and genomic imprinting of the HTR2A receptor gene T102C polymorphism in psychosis. Psychiatry Res 151, 243-248.
97. De Luca, V., Viggiano, E., Dhoot, R., Kennedy, J. L. & Wong, A. H. (2009). Methylation and QTDT analysis of the 5-HT2A receptor 102C allele: analysis of suicidality in major psychosis. J Psychiatr Res 43, 532-537.
98. Deutsch, S. I., Rosse, R. B., Mastropaolo, J., Long, K. D. & Gaskins, B. L. (2008). Epigenetic therapeutic strategies for the treatment of neuropsychiatric disorders: ready for prime time? Clin Neuropharmacol 31, 104-119.
99. Dong, E., Agis-Balboa, R. C., Simonini, M. V., Grayson, D. R., Costa, E. & Guidotti, A. (2005). Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionineinduced mouse model of schizophrenia. Proc Natl Acad Sci U S A 102, 12578-12583.
100. Dong, E., Guidotti, A., Grayson, D. R. & Costa, E. (2007). Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc Natl Acad Sci U S A 104, 4676-4681.
101. Dong, E., Nelson, M., Grayson, D. R., Costa, E. & Guidotti, A. (2008). Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc Natl Acad Sci U S A 105, 13614-13619.
102. Dracheva, S., Elhakem, S. L., McGurk, S. R., Davis, K. L. & Haroutunian, V. (2004). GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J Neurosci Res 76, 581-592.
103. Drapeau, E., Mayo, W., Aurousseau, C., Le Moal, M., Piazza, P. V. & Abrous, D. N. (2003). Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. Proc Natl Acad Sci U S A 100, 14385-14390.
104. Dudley, K. J., Li, X., Kobor, M. S., Kippin, T. E. & Bredy, T. W. (2011). Epigenetic mechanisms mediating vulnerability and resilience to psychiatric disorders. Neurosci Biobehav Rev 35, 1544-1551.
105. Duman, R. S. (2004). Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 5, 11-25.
106. Eastwood, S. L. & Harrison, P. J. (2005). Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73, 159-172.
107. Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. & Weinberger, D. R. (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98, 6917-6922.
108. Egan, M. F. & Weinberger, D. R. (1997). Neurobiology of schizophrenia. Curr Opin Neurobiol 7, 701-707.
109. Egger, G., Liang, G., Aparicio, A. & Jones, P. A. (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463.
110. Engel, G. L. (1977). The need for a new medical model: a challenge for biomedicine. Science 196, 129-136.
111. Ernst, C., Deleva, V., Deng, X., Sequeira, A., Pomarenski, A., Klempan, T., Ernst, N., Quirion, R., Gratton, A., Szyf, M. & Turecki, G. (2009). Alternative splicing, methylation state, and expression pro file of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch Gen Psychiatry 66, 22-32.
112. Erwin, J. A. & Lee, J. T. (2008). New twists in X-chromosome inactivation. Curr Opin Cell Biol 20, 349-355.
113. Fallin, M. D., Lasseter, V. K., Wolyniec, P. S., McGrath, J. A., Nestadt, G., Valle, D., Liang, K. Y. & Pulver, A. E. (2003). Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am J Hum Genet 73, 601-611.
114. Fatemi, S. H., Earle, J. A. & McMenomy, T. (2000). Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 5, 654-563.
115. Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards, V., Koss, M. P. & Marks, J. S. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med 14, 245-258.
116. Feng, J., Sun, G., Yan, J., Noltner, K., Li, W., Buzin, C. H., Longmate, J., Heston, L. L., Rossi, J. & Sommer, S. S. (2009). Evidence for X-chromosomal schizophrenia associated with microRNA alterations. PLoS ONE 4, e6121.
117. Ferreira, M. A., O'Donovan, M. C., Meng, Y. A., Jones, I. R., Ruderfer, D. M., Jones, L., Fan, J., Kirov, G., Perlis, R. H., Green, E. K., Smoller, J. W., Grozeva, D., Stone, J., Nikolov, I., Chambert, K., Hamshere, M. L., Nimgaonkar, V. L., Moskvina, V., Thase, M. E., Caesar, S., Sachs, G. S., Franklin, J., Gordon-Smith, K., Ardlie, K. G., Gabriel, S. B., Fraser, C., Blumenstiel, B., Defelice, M., Breen, G., Gill, M., Morris, D. W., Elkin, A., Muir, W. J., McGhee, K. A., Williamson, R., MacIntyre, D. J., MacLean, A. W., St, C. D., Robinson, M., Van Beck, M., Pereira, A. C., Kandaswamy, R., McQuillin, A., Collier, D. A., Bass, N. J., Young, A. H., Lawrence, J., Ferrier, I. N., Anjorin, A., Farmer, A., Curtis, D., Scolnick, E. M., McGuffin, P., Daly, M. J., Corvin, A. P., Holmans, P. A., Blackwood, D. H., Gurling, H. M., Owen, M. J., Purcell, S. M., Sklar, P. & Craddock, N. (2008). Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40, 1056-1058.
118. Fields, R. D. (2008). White matter in learning, cognition and psychiatric disorders. Trends Neurosci 31, 361-370.
119. Filion, G. J., Zhenilo, S., Salozhin, S., Yamada, D., Prokhortchouk, E. & Defossez, P. A. (2006). A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol Cell Biol 26, 169-181.
120. Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M. & Tsai, L. H. (2007). Recovery of learning and memory is associated with chromatin remodelling. Nature 447, 178-182.
121. Flynn, S. W., Lang, D. J., Mackay, A. L., Goghari, V., Vavasour, I. M., Whittall, K. P., Smith, G. N., Arango, V., Mann, J. J., Dwork, A. J., Falkai, P. & Honer, W. G. (2003). Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry 8, 811-820.
122. Fone, K. C. & Porkess, M. V. (2008). Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders. Neurosci Biobehav Rev 32, 1087-1102.
123. Francis, D. D. & Meaney, M. J. (1999). Maternal care and the development of stress responses. Curr Opin Neurobiol 9, 128-134.
124. Frank, E. & Landgraf, R. (2008). The vasopressin system-from antidiuresis to psychopathology. Eur J Pharmacol 583, 226-242.
125. Frankenburg, F. R. (2007). The role of one-carbon metabolism in schizophrenia and depression. Harv Rev Psychiatry 15, 146-160.
126. Frans, E. M., Sandin, S., Reichenberg, A., Lichtenstein, P., Langstrom, N. & Hultman, C. M. (2008). Advancing paternal age and bipolar disorder. Arch Gen Psychiatry 65, 1034-1040.
127. Fremeau, R. T., Jr., Troyer, M. D., Pahner, I., Nygaard, G. O., Tran, C. H., Reimer, R. J., Bellocchio, E. E., Fortin, D., Storm-Mathisen, J. & Edwards, R. H. (2001). The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31, 247-260.
128. Fukuchi, M., Nii, T., Ishimaru, N., Minamino, A., Hara, D., Takasaki, I., Tabuchi, A. & Tsuda, M. (2009). Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci Res 65, 35-43.
129. Fumagalli, F., Molteni, R., Racagni, G. & Riva, M. A. (2007). Stress during development: Impact on neuroplasticity and relevance to psychopathology. Prog Neurobiol 81, 197-217.
130. Gaddum, J. H. & Hameed, K. A. (1954). Drugs which antagonize 5-hydroxytryptamine. Br J Pharmacol Chemother 9, 240-248.
131. Gavin, D. P., Kartan, S., Chase, K., Grayson, D. R. & Sharma, R. P. (2008). Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. Schizophr Res 103, 330-332.
132. Gavin, D. P., Rosen, C., Chase, K., Grayson, D. R., Tun, N. & Sharma, R. P. (2009). Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. J Psychiatry Neurosci 34, 232-237.
133. Gavin, D. P. & Sharma, R. P. (2010). Histone modifications, DNA methylation, and schizophrenia. Neurosci Biobehav Rev 34, 882-888.
134. Glennon, R. A., Titeler, M. & McKenney, J. D. (1984). Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35, 2505-2511.
135. Gonzalez-Burgos, G. & Lewis, D. A. (2008). GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull 34, 944-961.
136. Goto, H., Tomono, Y., Ajiro, K., Kosako, H., Fujita, M., Sakurai, M., Okawa, K., Iwamatsu, A., Okigaki, T., Takahashi, T. & Inagaki, M. (1999). Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem 274, 25543-25549.
137. Gottesman, I. I. & Bertelsen, A. (1989). Con firming unexpressed genotypes for schizophrenia. Risks in the offspring of Fischer's Danish identical and fraternal discordant twins. Arch Gen Psychiatry 46, 867-872.
138. Gottesman, I. I. & Gould, T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160, 636-645.
139. Gottesman, I. I., Shields, J. & Hanson, D. R. (1982). Schizophrenia: The Epigenetic Puzzle. Cambridge, England: Cambridge University Press.
140. Grayson, D. R., Chen, Y., Costa, E., Dong, E., Guidotti, A., Kundakovic, M. & Sharma, R. P. (2006). The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacol Ther 111, 272-286.
141. Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A. & Costa, E. (2005). Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A 102, 9341-9346.
142. Grayson, D. R., Kundakovic, M. & Sharma, R. P. (2010). Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Mol Pharmacol 77, 126-135.
143. Groc, L., Choquet, D., Stephenson, F. A., Verrier, D., Manzoni, O. J. & Chavis, P. (2007). NMDA receptor surface traf ficking and synaptic subunit composition are developmentally regulated by the extracellular matrix protein Reelin. J Neurosci 27, 10165-10175.
144. Guenther, M. G., Levine, S. S., Boyer, L. A., Jaenisch, R. & Young, R. A. (2007). A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130, 77-88.
145. Guidotti, A., Auta, J., Chen, Y., Davis, J. M., Dong, E., Gavin, D. P., Grayson, D. R., Matrisciano, F., Pinna, G., Satta, R., Sharma, R. P., Tremolizzo, L. & Tueting, P. (2011). Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 60, 1007-1016.
146. Guidotti, A., Auta, J., Davis, J. M., Giorgi-Gerevini, V., Dwivedi, Y., Grayson, D. R., Impagnatiello, F., Pandey, G., Pesold, C., Sharma, R., Uzunov, D. & Costa, E. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 57, 1061-1069.
147. Guidotti, A., Dong, E., Kundakovic, M., Satta, R., Grayson, D. R. & Costa, E. (2009). Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci 30, 55-60.
148. Gupta, D. S., McCullumsmith, R. E., Beneyto, M., Haroutunian, V., Davis, K. L. & Meador-Woodruff, J. H. (2005). Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia. Synapse 57, 123-131.
149. Gurley, L. R., D'Anna, J. A., Barham, S. S., Deaven, L. L. & Tobey, R. A. (1978). Histone phosphorylation and chromatin structure during mitosis in Chinese hamster cells. Eur J Biochem 84, 1-15.
150. Hafner, H. (2003). Gender differences in schizophrenia. Psychoneuroendocrinology 28 Suppl 2, 17-54.
151. Haggarty, P., Hoad, G., Harris, S. E., Starr, J. M., Fox, H. C., Deary, I. J. & Whalley, L. J. (2010). Human intelligence and polymorphisms in the DNA methyltransferase genes involved in epigenetic marking. PLoS ONE 5, e11329.
152. Haidemenos, A., Kontis, D., Gazi, A., Kallai, E., Allin, M. & Lucia, B. (2007). Plasma homocysteine, folate and B12 in chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31, 1289-1296.
153. Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V. & Fienberg, A. A. (2001). Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 98, 4746-4751.
154. Hamer, D. (2002). Genetics. Rethinking behavior genetics. Science 298, 71-72.
155. Hannon, J. & Hoyer, D. (2008). Molecular biology of 5-HT receptors. Behav Brain Res 195, 198-213.
156. Hanson, J. L., Chung, M. K., Avants, B. B., Shirtcliff, E. A., Gee, J. C., Davidson, R. J. & Pollak, S. D. (2010). Early stress is associated with alterations in the orbitofrontal cortex: a tensor-based morphometry investigation of brain structure and behavioral risk. J Neurosci 30, 7466-7472.
157. Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F. & Weinberger, D. R. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23, 6690-6694.
158. Heim, C., Newport, D. J., Bonsall, R., Miller, A. H. & Nemeroff, C. B. (2001). Altered pituitaryadrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 158, 575-581.
159. Heuser, I., Yassouridis, A. & Holsboer, F. (1994). The combined dexamethasone/CRH test: a re fined laboratory test for psychiatric disorders. J Psychiatr Res 28, 341-356.
160. Himmelheber, A. M., Sarter, M. & Bruno, J. P. (2000). Increases in cortical acetylcholine release during sustained attention performance in rats. Brain Res Cogn Brain Res 9, 313-325.
161. Hof, P. R., Haroutunian, V., Friedrich, V. L., Jr., Byne, W., Buitron, C., Perl, D. P. & Davis, K. L. (2003). Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53, 1075-1085.
162. Honer, W. G., Falkai, P., Chen, C., Arango, V., Mann, J. J. & Dwork, A. J. (1999). Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 91, 1247-1255.
163. Hong, L., Schroth, G. P., Matthews, H. R., Yau, P. & Bradbury, E. M. (1993). Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA. J Biol Chem 268, 305-314.
164. Horrobin, D. F., Glen, A. I. & Vaddadi, K. (1994). The membrane hypothesis of schizophrenia. Schizophr Res 13, 195-207.
165. Hsieh, J. & Eisch, A. J. (2010). Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: unraveling the genome to understand the mind. Neurobiol Dis 39, 73-84.
166. Huang, H. S. & Akbarian, S. (2007). GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS ONE 2, e809.
167. Huang, H. S., Matevossian, A., Whittle, C., Kim, S. Y., Schumacher, A., Baker, S. P. & Akbarian, S. (2007). Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci 27, 11254-11262.
168. Hublitz, P., Albert, M. & Peters, A. H. (2009). Mechanisms of transcriptional repression by histone lysine methylation. Int J Dev Biol 53, 335-354.
169. Hughes, C. M., Rozenblatt-Rosen, O., Milne, T. A., Copeland, T. D., Levine, S. S., Lee, J. C., Hayes, D. N., Shanmugam, K. S., Bhattacharjee, A., Biondi, C. A., Kay, G. F., Hayward, N. K., Hess, J. L. & Meyerson, M. (2004). Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 13, 587-597.
170. Hurlock, E. C. (2001). Interferons: potential roles in affect. Med Hypotheses 56, 558-566.
171. Illingworth, R. S. & Bird, A. P. (2009). CpG islands-'a rough guide'. FEBS Lett 583, 1713-1720.
172. Inayama, Y., Yoneda, H., Sakai, T., Ishida, T., Nonomura, Y., Kono, Y., Takahata, R., Koh, J., Sakai, J., Takai, A., Inada, Y. & Asaba, H. (1996). Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am J Med Genet 67, 103-105.
173. Inlow, J. K. & Restifo, L. L. (2004). Molecular and comparative genetics of mental retardation. Genetics 166, 835-881.
174. Iwamoto, K., Bundo, M., Yamada, K., Takao, H., Iwayama, Y., Yoshikawa, T. & Kato, T. (2006). A family-based and case-control association study of SOX10 in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 141B, 477-481.
175. Iwamoto, K., Bundo, M., Yamada, K., Takao, H., Iwayama-Shigeno, Y., Yoshikawa, T. & Kato, T. (2005). DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 25, 5376-5381.
176. Jakobsson, J., Cordero, M. I., Bisaz, R., Groner, A. C., Busskamp, V., Bensadoun, J. C., Cammas, F., Losson, R., Mansuy, I. M., Sandi, C. & Trono, D. (2008). KAP1-mediated epigenetic repression in the forebrain modulates behavioral vulnerability to stress. Neuron 60, 818-831.
177. Javitt, D. C. (2010). Glutamatergic theories of schizophrenia. Isr J Psychiatry Relat Sci 47, 4-16.
178. Javitt, D. C. & Zukin, S. R. (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148, 1301-1308.
179. Jin, Y., Wang, Y., Walker, D. L., Dong, H., Conley, C., Johansen, J. & Johansen, K. M. (1999). JIL-1: a novel chromosomal tandem kinase implicated in transcriptional regulation in Drosophila. Mol Cell 4, 129-135.
180. Jirtle, R. L. & Skinner, M. K. (2007). Environmental epigenomics and disease susceptibility. Nat Rev Genet 8, 253-262.
181. Jones, P. A. & Baylin, S. B. (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3, 415-428.
182. Kaeberlein, M., McVey, M. & Guarente, L. (1999). The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13, 2570-2580.
183. Kaminsky, Z., Wang, S. C. & Petronis, A. (2006). Complex disease, gender and epigenetics. Ann Med 38, 530-544.
184. Kao, W. T., Wang, Y., Kleinman, J. E., Lipska, B. K., Hyde, T. M., Weinberger, D. R. & Law, A. J. (2010). Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci U S A 107, 15619-15624.
185. Kato, M. V., Ikawa, Y., Hayashizaki, Y. & Shibata, H. (1998). Paternal imprinting of mouse serotonin receptor 2A gene Htr2 in embryonic eye: a conserved imprinting regulation on the RB/Rb locus. Genomics 47, 146-148.
186. Kato, T. (2007). Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci 61, 3-19.
187. Katona, I., Sperlagh, B., Sik, A., Kafalvi, A., Vizi, E. S., Mackie, K. & Freund, T. F. (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19, 4544-4558.
188. Kazantsev, A. G. & Thompson, L. M. (2008). Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 7, 854-868.
189. Kessaris, N., Pringle, N. & Richardson, W. D. (2001). Ventral neurogenesis and the neuron-glial switch. Neuron 31, 677-680.
190. Ketter, T. A. (2010). Diagnostic features, prevalence, and impact of bipolar disorder. J Clin Psychiatry 71, e14.
191. Kety, S. S., Wender, P. H., Jacobsen, B., Ingraham, L. J., Jansson, L., Faber, B. & Kinney, D. K. (1994). Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark. Arch Gen Psychiatry 51, 442-455.
192. Khalil, A. M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea, M. D., Thomas, K., Presser, A., Bernstein, B. E., Van Oudenaarden, A., Regev, A., Lander, E. S. & Rinn, J. L. (2009). Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 106, 11667-11672.
193. Kim, J. S., Kornhuber, H. H., Schmid-Burgk, W. & Holzmuller, B. (1980). Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20, 379-382.
194. Kim, T., Park, J. K., Kim, H. J., Chung, J. H. & Kim, J. W. (2010). Association of histone deacetylase genes with schizophrenia in Korean population. Psychiatry Res 178, 266-269.
195. Kim, V. N. (2005). MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6, 376-385.
196. Klose, R. J. & Bird, A. P. (2006). Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31, 89-97.
197. Knable, M. B., Barci, B. M., Webster, M. J., Meador-Woodruff, J. & Torrey, E. F. (2004). Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9, 609-620.
198. Knight, C. G., Zitzmann, N., Prabhakar, S., Antrobus, R., Dwek, R., Hebestreit, H. & Rainey, P. B. (2006). Unraveling adaptive evolution: how a single point mutation affects the protein coregulation network. Nat Genet 38, 1015-1022.
199. Kontkanen, O., Lakso, M., Wong, G. & Castren, E. (2002). Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology 27, 152-162.
200. Kouzarides, T. (2007). Chromatin modi fications and their function. Cell 128, 693-705.
201. Kouzmenko, A. P., Hayes, W. L., Pereira, A. M., Dean, B., Burnet, P. W. & Harrison, P. J. (1997). 5-HT2A receptor polymorphism and steady state receptor expression in schizophrenia. Lancet 349, 1815.
202. Kouzmenko, A. P., Scaffidi, A., Pereira, A. M., Hayes, W. L., Copolov, D. L. & Dean, B. (1999). No correlation between A (-1438) G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia. Hum Hered 49, 103-105.
203. Koyrakh, L., Lujan, R., Colon, J., Karschin, C., Kurachi, Y., Karschin, A. & Wickman, K. (2005). Molecular and cellular diversity of neuronal G-protein-gated potassium channels. J Neurosci 25, 11468-11478.
204. Krebs, M. O., Bellon, A., Mainguy, G., Jay, T. M. & Frieling, H. (2009). One-carbon metabolism and schizophrenia: current challenges and future directions. Trends Mol Med 15, 562-570.
205. Krishnan, V. & Nestler, E. J. (2010). Linking molecules to mood: new insight into the biology of depression. Am J Psychiatry 167, 1305-1320.
206. Krystal, J. H., Mathew, S. J., D'Souza, D. C., Garakani, A., Gunduz-Bruce, H. & Charney, D. S. (2010). Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs 24, 669-693.
207. Kundakovic, M., Chen, Y., Costa, E. & Grayson, D. R. (2007). DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol Pharmacol 71, 644-653.
208. Kundakovic, M., Chen, Y., Guidotti, A. & Grayson, D. R. (2009). The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol Pharmacol 75, 342-354.
209. Kuratomi, G., Iwamoto, K., Bundo, M., Kusumi, I., Kato, N., Iwata, N., Ozaki, N. & Kato, T. (2008). Aberrant DNA methylation associated with bipolar disorder identi fied from discordant monozygotic twins. Mol Psychiatry 13, 429-441.
210. Kustova, Y., Sei, Y., Morse, H. C., Jr. & Basile, A. S. (1998). The influence of a targeted deletion of the IFNgamma gene on emotional behaviors. Brain Behav Immun 12, 308-324.
211. Kwon, O. B., Paredes, D., Gonzalez, C. M., Neddens, J., Hernandez, L., Vullhorst, D. & Buonanno, A. (2008). Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors. Proc Natl Acad Sci U S A 105, 15587-15592.
212. Lau, C. G. & Zukin, R. S. (2007). NMDA receptor traf ficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8, 413-426.
213. Lee, C. & Scherer, S. W. (2010). The clinical context of copy number variation in the human genome. Expert Rev Mol Med 12, e8.
214. Leonard, B. E. (2010). The concept of depression as a dysfunction of the immune system. Curr Immunol Rev 6, 205-212.
215. Levenson, J. M., Roth, T. L., Lubin, F. D., Miller, C. A., Huang, I. C., Desai, P., Malone, L. M. & Sweatt, J. D. (2006). Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 281, 15763-15773.
216. Levine, J., Stahl, Z., Sela, B. A., Gavendo, S., Ruderman, V. & Belmaker, R. H. (2002). Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry 159, 1790-1792.
217. Li, E. (2002). Chromatin modi fication and epigenetic reprogramming in mammalian development. Nat Rev Genet 3, 662-673.
218. Li, J., Guo, Y., Schroeder, F. A., Youngs, R. M., Schmidt, T. W., Ferris, C., Konradi, C. & Akbarian, S. (2004). Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem 90, 1117-1131.
219. Lim, D. A., Huang, Y. C., Swigut, T., Mirick, A. L., Garcia-Verdugo, J. M., Wysocka, J., Ernst, P. & Alvarez-Buylla, A. (2009). Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature 458, 529-533.
220. Lin, Q., Wei, W., Coelho, C. M., Li, X., Baker-Andresen, D., Dudley, K., Ratnu, V. S., Boskovic, Z., Kobor, M. S., Sun, Y. E. & Bredy, T. W. (2011). The brain-specific microRNA miR-128b regulates the formation of fear-extinction memory. Nat Neurosci 14, 1115-1117.
221. Lippmann, M., Bress, A., Nemeroff, C. B., Plotsky, P. M. & Monteggia, L. M. (2007). Longterm behavioural and molecular alterations associated with maternal separation in rats. Eur J Neurosci 25, 3091-3098.
222. Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S. & Grace, A. A. (2008). Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 31, 234-242.
223. Liu, C. M., Liu, Y. L., Fann, C. S., Chen, W. J., Yang, W. C., Ouyang, W. C., Chen, C. Y., Jou, Y. S., Hsieh, M. H., Liu, S. K., Hwang, T. J., Faraone, S. V., Tsuang, M. T. & Hwu, H. G. (2007). Association evidence of schizophrenia with distal genomic region of NOTCH4 in Taiwanese families. Genes Brain Behav 6, 497-502.
224. Liu, Q. R., Lu, L., Zhu, X. G., Gong, J. P., Shaham, Y. & Uhl, G. R. (2006). Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Res 1067, 1-12.
225. Loganathan, M., Lohano, K., Roberts, R. J., Gao, Y. & El Mallakh, R. S. (2010). When to suspect bipolar disorder. J Fam Pract 59, 682-688.
226. Longart, M., Liu, Y., Karavanova, I. & Buonanno, A. (2004). Neuregulin-2 is developmentally regulated and targeted to dendrites of central neurons. J Comp Neurol 472, 156-172.
227. Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. & Murray, C. J. L. (2006). Global Burden of Disease and Risk Factors. New York, Washington, D. C.: Oxford University Press, The World Bank.
228. Lopez-Atalaya, J. P., Ciccarelli, A., Viosca, J., Valor, L. M., Jimenez-Minchan, M., Canals, S., Giustetto, M. & Barco, A. (2011). CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. EMBO J 30, 4287-4298.
229. Lu, B. & Martinowich, K. (2008). Cell biology of BDNF and its relevance to schizophrenia. Novartis Found Symp 289, 119-129.
230. Lubin, F. D., Roth, T. L. & Sweatt, J. D. (2008). Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J Neurosci 28, 10576-10586.
231. Ma, Y. Y., Shek, C. C., Wong, M. C., Yip, K. C., Ng, R. M., Nguyen, D. G. & Poon, T. K. (2009). Homocysteine level in schizophrenia patients. Aust N Z J Psychiatry 43, 760-765.
232. Maeno, N., Takahashi, N., Saito, S., Ji, X., Ishihara, R., Aoyama, N., Branko, A., Miura, H., Ikeda, M., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Iwata, N., Inada, T. & Ozaki, N. (2007). Association of SOX10 with schizophrenia in the Japanese population. Psychiatr Genet 17, 227-231.
233. Maes, O. C., Chertkow, H. M., Wang, E. & Schipper, H. M. (2009). MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders. Curr Genomics 10, 154-168.
234. Mahadevan, L. C., Willis, A. C. & Barratt, M. J. (1991). Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell 65, 775-783.
235. Malaspina, D., Corcoran, C., Fahim, C., Berman, A., Harkavy-Friedman, J., Yale, S., Goetz, D., Goetz, R., Harlap, S. & Gorman, J. (2002). Paternal age and sporadic schizophrenia: evidence for de novo mutations. Am J Med Genet 114, 299-303.
236. Malik, K. & Brown, K. W. (2000). Epigenetic gene deregulation in cancer. Br J Cancer 83, 1583-1588.
237. Maloku, E., Kadriu, B., Zhubi, A., Dong, E., Pibiri, F., Satta, R. & Guidotti, A. (2011). Selective alpha4beta2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons. Neuropsychopharmacology 36, 1366-1374.
238. Marksteiner, J., Weiss, U., Weis, C., Laslop, A., Fischer-Colbrie, R., Humpel, C., Feldon, J. & Fleischhacker, W. W. (2001). Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment. Neuroscience 104, 325-333.
239. Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G. & Sun, Y. E. (2003). DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302, 890-893.
240. Matrisciano, F., Dong, E., Gavin, D. P., Nicoletti, F. & Guidotti, A. (2011). Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain. Mol Pharmacol 80, 174-182.
241. Mattick, J. S. & Makunin, I. V. (2005). Small regulatory RNAs in mammals. Hum Mol Genet 14, R121-R132.
242. McClelland, S., Korosi, A., Cope, J., Ivy, A. & Baram, T. Z. (2011). Emerging roles of epigenetic mechanisms in the enduring effects of early-life stress and experience on learning and memory. Neurobiol Learn Mem 96, 79-88.
243. McFarlane, A., Clark, C. R., Bryant, R. A., Williams, L. M., Niaura, R., Paul, R. H., Hitsman, B. L., Stroud, L., Alexander, D. M. & Gordon, E. (2005). The impact of early life stress on psychophysiological, personality and behavioral measures in 740 non-clinical subjects. J Integr Neurosci 4, 27-40.
244. McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonte, B., Szyf, M., Turecki, G. & Meaney, M. J. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12, 342-348.
245. McGrath, J., Saha, S., Chant, D. & Welham, J. (2008). Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30, 67-76.
246. McQuillin, A., Rizig, M. & Gurling, H. M. (2007). A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics 17, 605-617.
247. Meaney, M. J. & Szyf, M. (2005). Maternal care as a model for experience-dependent chromatin plasticity? Trends Neurosci 28, 456-463.
248. Mehler, M. F. (2008). Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol 86, 305-341.
249. Mello, A. F., Mello, M. F., Carpenter, L. L. & Price, L. H. (2003). Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Rev Bras Psiquiatr 25, 231-238.
250. Meltzer, H. Y. (1999). The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21, 106S-115S.
251. Meola, N., Gennarino, V. A. & Banfi, S. (2009). microRNAs and genetic diseases. Pathogenetics 2:7.
252. Merikangas, A. K., Corvin, A. P. & Gallagher, L. (2009). Copy-number variants in neurodevelopmental disorders: promises and challenges. Trends Genet 25, 536-544.
253. Meza-Sosa, K. F., Valle-Garcia, D., Pedraza-Alva, G. & Perez-Martinez, L. (2012). Role of microRNAs in central nervous system development and pathology. J Neurosci Res 90, 1-12.
254. Migliore, L. & Coppede, F. (2009). Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat Res 667, 82-97.
255. Mill, J. & Petronis, A. (2007). Molecular studies of major depressive disorder: the epigenetic perspective. Mol Psychiatry 12, 799-814.
256. Mill, J., Tang, T., Kaminsky, Z., Khare, T., Yazdanpanah, S., Bouchard, L., Jia, P., Assadzadeh, A., Flanagan, J., Schumacher, A., Wang, S. C. & Petronis, A. (2008). Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 82, 696-711.
257. Miller, B. H. & Wahlestedt, C. (2010). MicroRNA dysregulation in psychiatric disease. Brain Res 1338, 89-99.
258. Miller, C. A. & Sweatt, J. D. (2007). Covalent modi fication of DNA regulates memory formation. Neuron 53, 857-869.
259. Mirnics, K., Levitt, P. & Lewis, D. A. (2004). DNA microarray analysis of postmortem brain tissue. Int Rev Neurobiol 60, 153-181.
260. Miska, E. A., Alvarez-Saavedra, E., Townsend, M., Yoshii, A., Sestan, N., Rakic, P., Constantine-Paton, M. & Horvitz, H. R. (2004). Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 5, R68.
261. Miyaoka, T., Seno, H. & Ishino, H. (1999). Increased expression of Wnt-1 in schizophrenic brains. Schizophr Res 38, 1-6.
262. Mohn, F. & Schubeler, D. (2009). Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet 25, 129-136.
263. Money, T. T., Scarr, E., Udawela, M., Gibbons, A. S., Jeon, W. J., Seo, M. S. & Dean, B. (2010). Treating schizophrenia: novel targets for the cholinergic system. CNS Neurol Disord Drug Targets 9, 241-256.
264. Morar, B., Dragovic, M., Waters, F. A., Chandler, D., Kalaydjieva, L. & Jablensky, A. (2011). Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition. Mol Psychiatry 16, 860-866.
265. Morrison, B. E., Majdzadeh, N. & D'Mello, S. R. (2007). Histone deacetylases: focus on the nervous system. Cell Mol Life Sci 64, 2258-2269.
266. Moser, D., Ekawardhani, S., Kumsta, R., Palmason, H., Bock, C., Athanassiadou, Z., Lesch, K. P. & Meyer, J. (2009). Functional analysis of a potassium-chloride co-transporter 3 (SLC12A6) promoter polymorphism leading to an additional DNA methylation site. Neuropsychopharmacology 34, 458-467.
267. Mottet, D. & Castronovo, V. (2008). Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis 25, 183-189.
268. Murgatroyd, C., Patchev, A. V., Wu, Y., Micale, V., Bockmuhl, Y., Fischer, D., Holsboer, F., Wotjak, C. T., Almeida, O. F. & Spengler, D. (2009). Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 12, 1559-1566.
269. Nakahata, Y., Grimaldi, B., Sahar, S., Hirayama, J. & Sassone-Corsi, P. (2007). Signaling to the circadian clock: plasticity by chromatin remodeling. Curr Opin Cell Biol 19, 230-237.
270. Nakatani, T., Minaki, Y., Kumai, M. & Ono, Y. (2007). Helt determines GABAergic over glutamatergic neuronal fate by repressing Ngn genes in the developing mesencephalon. Development 134, 2783-2793.
271. Neddens, J., Vullhorst, D., Paredes, D. & Buonanno, A. (2009). Neuregulin links dopaminergic and glutamatergic neurotransmission to control hippocampal synaptic plasticity. Commun Integr Biol 2, 261-264.
272. Nelson, E. D., Kavalali, E. T. & Monteggia, L. M. (2008). Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J Neurosci 28, 395-406.
273. Nestler, E. J., Barrot, M., Dileone, R. J., Eisch, A. J., Gold, S. J. & Monteggia, L. M. (2002). Neurobiology of depression. Neuron 34, 13-25.
274. Nowak, S. J. & Corces, V. G. (2004). Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 20, 214-220.
275. Nowak, S. J., Pai, C. Y. & Corces, V. G. (2003). Protein phosphatase 2A activity affects histone H3 phosphorylation and transcription in Drosophila melanogaster. Mol Cell Biol 23, 6129-6138.
276. O'Donovan, M. C., Craddock, N. J. & Owen, M. J. (2009). Genetics of psychosis; insights from views across the genome. Hum Genet 126, 3-12.
277. Oberlander, T. F., Weinberg, J., Papsdorf, M., Grunau, R., Misri, S. & Devlin, A. M. (2008). Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 3, 97-106.
278. Ordway, J. M. & Curran, T. (2002). Methylation matters: modeling a manageable genome. Cell Growth Differ 13, 149-162.
279. Paradisi, A., Pasquariello, N., Barcaroli, D. & Maccarrone, M. (2008). Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. J Biol Chem 283, 6005-6012.
280. Pariante, C. M. (2008). Pituitary volume in psychosis: the first review of the evidence. J Psychopharmacol 22, 76-81.
281. Pariante, C. M. & Lightman, S. L. (2008). The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31, 464-468.
282. Parnas, J. & Jorgensen, A. (1989). Pre-morbid psychopathology in schizophrenia spectrum. Br J Psychiatry 155, 623-627.
283. Paylor, R., Zhao, Y., Libbey, M., Westphal, H. & Crawley, J. N. (2001). Learning impairments and motor dysfunctions in adult Lhx5-deficient mice displaying hippocampal disorganization. Physiol Behav 73, 781-792.
284. Perkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., Parker, J. S., Jin, J. & Hammond, S. M. (2007). microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8, R27.
285. Pesold, C., Impagnatiello, F., Pisu, M. G., Uzunov, D. P., Costa, E., Guidotti, A. & Caruncho, H. J. (1998). Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc Natl Acad Sci U S A 95, 3221-3226.
286. Peterson, C. L. & Laniel, M. A. (2004). Histones and histone modi fications. Curr Biol 14, R546-R551.
287. Petronis, A. (2000). The genes for major psychosis: aberrant sequence or regulation? Neuropsychopharmacology 23, 1-12.
288. Petronis, A., Paterson, A. D. & Kennedy, J. L. (1999). Schizophrenia: an epigenetic puzzle? Schizophr Bull 25, 639-655.
289. Picchioni, M. M. & Murray, R. M. (2007). Schizophrenia. BMJ 335, 91-95.
290. Pidsley, R., Dempster, E. L. & Mill, J. (2010). Brain weight in males is correlated with DNA methylation at IGF2. Mol Psychiatry 15, 880-881.
291. Pidsley, R. & Mill, J. (2011). Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research. Biol Psychiatry 69, 146-156.
292. Pinal, C. S. & Tobin, A. J. (1998). Uniqueness and redundancy in GABA production. Perspect Dev Neurobiol 5, 109-118.
293. Polesskaya, O. O., Aston, C. & Sokolov, B. P. (2006). Allele C-specific methylation of the 5-HT2A receptor gene: evidence for correlation with its expression and expression of DNA methylase DNMT1. J Neurosci Res 83, 362-373.
294. Polesskaya, O. O. & Sokolov, B. P. (2002). Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res 67, 812-822.
295. Ponjavic, J., Oliver, P. L., Lunter, G. & Ponting, C. P. (2009). Genomic and transcriptional colocalization of protein-coding and long non-coding RNA pairs in the developing brain. PLoS Genet 5, e1000617.
296. Portela, A. & Esteller, M. (2010). Epigenetic modi fications and human disease. Nat Biotechnol 28, 1057-1068.
297. Preuss, U., Landsberg, G. & Scheidtmann, K. H. (2003). Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase. Nucleic Acids Res 31, 878-885.
298. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O'Donovan, M. C., Sullivan, P. F. & Sklar, P. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752.
299. Qureshi, I. A., Mattick, J. S. & Mehler, M. F. (2010). Long non-coding RNAs in nervous system function and disease. Brain Res 1338, 20-35.
300. Rajkowska, G. & Miguel-Hidalgo, J. J. (2007). Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 6, 219-233.
301. Reich, T., Clayton, P. J. & Winokur, G. (1969). Family history studies: V. The genetics of mania. Am J Psychiatry 125, 1358-1369.
302. Renthal, W. & Nestler, E. J. (2008). Epigenetic mechanisms in drug addiction. Trends Mol Med 14, 341-350.
303. Restrepo, A., Smith, C. A., Agnihotri, S., Shekarforoush, M., Kongkham, P. N., Seol, H. J., Northcott, P. & Rutka, J. T. (2011). Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas. Neuro Oncol 13, 42-50.
304. Reul, J. M., Hesketh, S. A., Collins, A. & Mecinas, M. G. (2009). Epigenetic mechanisms in the dentate gyrus act as a molecular switch in hippocampus-associated memory formation. Epigenetics 4, 434-439.
305. Rigucci, S., Serafini, G., Pompili, M., Kotzalidis, G. D. & Tatarelli, R. (2010). Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies. World J Biol Psychiatry 11, 165-180.
306. Robinson, S. A., Loiacono, R. E., Christopoulos, A., Sexton, P. M. & Malone, D. T. (2010). The effect of social isolation on rat brain expression of genes associated with endocannabinoid signaling. Brain Res 1343, 153-167.
307. Roffman, J. L., Weiss, A. P., Purcell, S., Caffalette, C. A., Freudenreich, O., Henderson, D. C., Bottiglieri, T., Wong, D. H., Halsted, C. H. & Goff, D. C. (2008). Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia. Biol Psychiatry 63, 42-48.
308. Rosa, A., Picchioni, M. M., Kalidindi, S., Loat, C. S., Knight, J., Toulopoulou, T., Vonk, R., Van Der Schot, A. C., Nolen, W., Kahn, R. S., McGuffin, P., Murray, R. M. & Craig, I. W. (2008). Differential methylation of the X-chromosome is a possible source of discordance for bipolar disorder female monozygotic twins. Am J Med Genet B Neuropsychiatr Genet 147B, 459-462.
309. Roth, T. L., Lubin, F. D., Funk, A. J. & Sweatt, J. D. (2009). Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 65, 760-769.
310. Roth, T. L. & Sweatt, J. D. (2009). Regulation of chromatin structure in memory formation. Curr Opin Neurobiol 19, 336-342.
311. Rottach, A., Leonhardt, H. & Spada, F. (2009). DNA methylation-mediated epigenetic control. J Cell Biochem 108, 43-51.
312. Ruzicka, W. B., Zhubi, A., Veldic, M., Grayson, D. R., Costa, E. & Guidotti, A. (2007). Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. Mol Psychiatry 12, 385-397.
313. Satta, R., Maloku, E., Zhubi, A., Pibiri, F., Hajos, M., Costa, E. & Guidotti, A. (2008). Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proc Natl Acad Sci U S A 105, 16356-16361.
314. Schratt, G. M., Tuebing, F., Nigh, E. A., Kane, C. G., Sabatini, M. E., Kiebler, M. & Greenberg, M. E. (2006). A brain-specific microRNA regulates dendritic spine development. Nature 439, 283-289.
315. Schroeder, F. A., Lin, C. L., Crusio, W. E. & Akbarian, S. (2007). Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62, 55-64.
316. Schroeder, M., Krebs, M. O., Bleich, S. & Frieling, H. (2010). Epigenetics and depression: current challenges and new therapeutic options. Curr Opin Psychiatry 23, 588-592.
317. Schwab, S. G., Hallmayer, J., Albus, M., Lerer, B., Eckstein, G. N., Borrmann, M., Segman, R. H., Hanses, C., Freymann, J., Yakir, A., Trixler, M., Falkai, P., Rietschel, M., Maier, W. & Wildenauer, D. B. (2000). A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry 5, 638-649.
318. Segurado, R., Detera-Wadleigh, S. D., Levinson, D. F., Lewis, C. M., Gill, M., Nurnberger, J. I., Jr., Craddock, N., DePaulo, J. R., Baron, M., Gershon, E. S., Ekholm, J., Cichon, S., Turecki, G., Claes, S., Kelsoe, J. R., Schofield, P. R., Badenhop, R. F., Morissette, J., Coon, H., Blackwood, D., McInnes, L. A., Foroud, T., Edenberg, H. J., Reich, T., Rice, J. P., Goate, A., McInnis, M. G., McMahon, F. J., Badner, J. A., Goldin, L. R., Bennett, P., Willour, V. L., Zandi, P. P., Liu, J., Gilliam, C., Juo, S. H., Berrettini, W. H., Yoshikawa, T., Peltonen, L., Lonnqvist, J., Nothen, M. M., Schumacher, J., Windemuth, C., Rietschel, M., Propping, P., Maier, W., Alda, M., Grof, P., Rouleau, G. A., Del Favero, J., Van Broeckhoven, C., Mendlewicz, J., Adolfsson, R., Spence, M. A., Luebbert, H., Adams, L. J., Donald, J. A., Mitchell, P. B., Barden, N., Shink, E., Byerley, W., Muir, W., Visscher, P. M., Macgregor, S., Gurling, H., Kalsi, G., McQuillin, A., Escamilla, M. A., Reus, V. I., Leon, P., Freimer, N. B., Ewald, H., Kruse, T. A., Mors, O., Radhakrishna, U., Blouin, J. L., Antonarakis, S. E. & Akarsu, N. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 73, 49-62.
319. Selye, H. (1956). The stress-concept as it presents itself in 1956. Antibiot Chemother 3, 1-17.
320. Serretti, A. & Mandelli, L. (2008). The genetics of bipolar disorder: genome 'hot regions', genes, new potential candidates and future directions. Mol Psychiatry 13, 742-771.
321. Sharma, R. P., Grayson, D. R. & Gavin, D. P. (2008). Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr Res 98, 111-117.
322. Sharma, R. P., Rosen, C., Kartan, S., Guidotti, A., Costa, E., Grayson, D. R. & Chase, K. (2006). Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophr Res 88, 227-231.
323. Shimabukuro, M., Jinno, Y., Fuke, C. & Okazaki, Y. (2006). Haloperidol treatment induces tissue- and sex-specific changes in DNA methylation: a control study using rats. Behav Brain Funct 2:37.
324. Simonini, M. V., Camargo, L. M., Dong, E., Maloku, E., Veldic, M., Costa, E. & Guidotti, A. (2006). The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci U S A 103, 1587-1592.
325. Smith, C. L., Bolton, A. & Nguyen, G. (2010). Genomic and epigenomic instability, fragile sites, schizophrenia and autism. Curr Genomics 11, 447-469.
326. Smith, R. E., Haroutunian, V., Davis, K. L. & Meador-Woodruff, J. H. (2001). Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia. Neuroreport 12, 2885-2887.
327. Sproule, D. M. & Kaufmann, P. (2008). Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 1142, 133-158.
328. Stadler, F., Kolb, G., Rubusch, L., Baker, S. P., Jones, E. G. & Akbarian, S. (2005). Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain. J Neurochem 94, 324-336.
329. Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietilainen, O. P., Mors, O., Mortensen, P. B., Sigurdsson, E., Gustafsson, O., Nyegaard, M., Tuulio-Henriksson, A., Ingason, A., Hansen, T., Suvisaari, J., Lonnqvist, J., Paunio, T., Borglum, A. D., Hartmann, A., Fink-Jensen, A., Nordentoft, M., Hougaard, D., Norgaard-Pedersen, B., Bottcher, Y., Olesen, J., Breuer, R., Moller, H. J., Giegling, I., Rasmussen, H. B., Timm, S., Mattheisen, M., Bitter, I., Rethelyi, J. M., Magnusdottir, B. B., Sigmundsson, T., Olason, P., Masson, G., Gulcher, J. R., Haraldsson, M., Fossdal, R., Thorgeirsson, T. E., Thorsteinsdottir, U., Ruggeri, M., Tosato, S., Franke, B., Strengman, E., Kiemeney, L. A., Melle, I., Djurovic, S., Abramova, L., Kaleda, V., Sanjuan, J., De Frutos, R., Bramon, E., Vassos, E., Fraser, G., Ettinger, U., Picchioni, M., Walker, N., Toulopoulou, T., Need, A. C., Ge, D., Yoon, J. L., Shianna, K. V., Freimer, N. B., Cantor, R. M., Murray, R., Kong, A., Golimbet, V., Carracedo, A., Arango, C., Costas, J., Jonsson, E. G., Terenius, L., Agartz, I., Petursson, H., Nothen, M. M., Rietschel, M., Matthews, P. M., Muglia, P., Peltonen, L., St Clair, D., Goldstein, D. B., Stefansson, K. & Collier, D. A. (2009). Common variants conferring risk of schizophrenia. Nature 460, 744-747.
330. Stimson, L. & La Thangue, N. B. (2009). Biomarkers for predicting clinical responses to HDAC inhibitors. Cancer Lett 280, 177-183.
331. Stock, J. K., Giadrossi, S., Casanova, M., Brookes, E., Vidal, M., Koseki, H., Brockdorff, N., Fisher, A. G. & Pombo, A. (2007). Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat Cell Biol 9, 1428-1435.
332. Stolt, C. C., Rehberg, S., Ader, M., Lommes, P., Riethmacher, D., Schachner, M., Bartsch, U. & Wegner, M. (2002). Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev 16, 165-170.
333. Straub, R. E., Lipska, B. K., Egan, M. F., Goldberg, T. E., Callicott, J. H., Mayhew, M. B., Vakkalanka, R. K., Kolachana, B. S., Kleinman, J. E. & Weinberger, D. R. (2007). Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry 12, 854-869.
334. Sugai, T., Kawamura, M., Iritani, S., Araki, K., Makifuchi, T., Imai, C., Nakamura, R., Kakita, A., Takahashi, H. & Nawa, H. (2004). Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. Ann N Y Acad Sci 1025, 84-91.
335. Suter, C. M., Martin, D. I. & Ward, R. L. (2004). Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 36, 497-501.
336. Szeszko, P. R., Lipsky, R., Mentschel, C., Robinson, D., Gunduz-Bruce, H., Sevy, S., Ashtari, M., Napolitano, B., Bilder, R. M., Kane, J. M., Goldman, D. & Malhotra, A. K. (2005). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 10, 631-636.
337. Szyf, M. (2010). DNA methylation and demethylation probed by small molecules. Biochim Biophys Acta 1799, 750-759.
338. Taft, R. J., Pang, K. C., Mercer, T. R., Dinger, M. & Mattick, J. S. (2010). Non-coding RNAs: regulators of disease. J Pathol 220, 126-139.
339. Takai, D. & Jones, P. A. (2002). Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 99, 3740-3745.
340. Tamminga, J., Koturbash, I., Baker, M., Kutanzi, K., Kathiria, P., Pogribny, I. P., Sutherland, R. J. & Kovalchuk, O. (2008). Paternal cranial irradiation induces distant bystander DNA damage in the germline and leads to epigenetic alterations in the offspring. Cell Cycle 7, 1238-1245.
341. Thomassin, H., Flavin, M., Espinas, M. L. & Grange, T. (2001). Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J 20, 1974-1983.
342. Titeler, M., Lyon, R. A. & Glennon, R. A. (1988). Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology (Berl) 94, 213-216.
343. Tkachev, D., Mimmack, M. L., Ryan, M. M., Wayland, M., Freeman, T., Jones, P. B., Starkey, M., Webster, M. J., Yolken, R. H. & Bahn, S. (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798-805.
344. Torrey, E. F., Barci, B. M., Webster, M. J., Bartko, J. J., Meador-Woodruff, J. H. & Knable, M. B. (2005). Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 57, 252-260.
345. Tremolizzo, L., Carboni, G., Ruzicka, W. B., Mitchell, C. P., Sugaya, I., Tueting, P., Sharma, R., Grayson, D. R., Costa, E. & Guidotti, A. (2002). An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci U S A 99, 17095-17100.
346. Tremolizzo, L., Doueiri, M. S., Dong, E., Grayson, D. R., Davis, J., Pinna, G., Tueting, P., Rodriguez-Menendez, V., Costa, E. & Guidotti, A. (2005). Valproate corrects the schizophrenia-like epigenetic behavioral modi fications induced by methionine in mice. Biol Psychiatry 57, 500-509.
347. Tsankova, N., Renthal, W., Kumar, A. & Nestler, E. J. (2007). Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8, 355-367.
348. Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L. & Nestler, E. J. (2006). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9, 519-525.
349. Tsankova, N. M., Kumar, A. & Nestler, E. J. (2004). Histone modi fications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci 24, 5603-5610.
350. Tunbridge, E. M., Harrison, P. J., Warden, D. R., Johnston, C., Refsum, H. & Smith, A. D. (2008). Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels. Am J Med Genet B Neuropsychiatr Genet 147B, 996-999.
351. Tunbridge, E. M., Harrison, P. J. & Weinberger, D. R. (2006). Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 60, 141-151.
352. Tunbridge, E. M., Lane, T. A. & Harrison, P. J. (2007). Expression of multiple catechol-omethyltransferase (COMT) mRNA variants in human brain. Am J Med Genet B Neuropsychiatr Genet 144B, 834-839.
353. Uranova, N. A., Vostrikov, V. M., Orlovskaya, D. D. & Rachmanova, V. I. (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67, 269-275.
354. Van Den Buuse, M., Garner, B. & Koch, M. (2003). Neurodevelopmental animal models of schizophrenia: effects on prepulse inhibition. Curr Mol Med 3, 459-471.
355. Veldic, M., Caruncho, H. J., Liu, W. S., Davis, J., Satta, R., Grayson, D. R., Guidotti, A. & Costa, E. (2004). DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc Natl Acad Sci U S A 101, 348-353.
356. Veldic, M., Guidotti, A., Maloku, E., Davis, J. M. & Costa, E. (2005). In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci U S A 102, 2152-2157.
357. Veldic, M., Kadriu, B., Maloku, E., Agis-Balboa, R. C., Guidotti, A., Davis, J. M. & Costa, E. (2007). Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res 91, 51-61.
358. Vo, N., Klein, M. E., Varlamova, O., Keller, D. M., Yamamoto, T., Goodman, R. H. & Impey, S. (2005). A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A 102, 16426-16431.
359. Volterra, A. & Meldolesi, J. (2005). Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6, 626-640.
360. Waddington, C. (1942). The epigenotype. Endeavour 1, 18-20.
361. Walker, J. C. & Harland, R. M. (2009). microRNA-24a is required to repress apoptosis in the developing neural retina. Genes Dev 23, 1046-1051.
362. Wang, Y. C., Chen, J. Y., Chen, M. L., Chen, C. H., Lai, I. C., Chen, T. T., Hong, C. J., Tsai, S. J. & Liou, Y. J. (2008). Neuregulin 3 genetic variations and susceptibility to schizophrenia in a Chinese population. Biol Psychiatry 64, 1093-1096.
363. Wassef, A., Baker, J. & Kochan, L. D. (2003). GABA and schizophrenia: a review of basic science and clinical studies. J Clin Psychopharmacol 23, 601-640.
364. Wassef, A. A., Hafiz, N. G., Hampton, D. & Molloy, M. (2001). Divalproex sodium augmentation of haloperidol in hospitalized patients with schizophrenia: clinical and economic implications. J Clin Psychopharmacol 21, 21-26.
365. Waterland, R. A., Dolinoy, D. C., Lin, J. R., Smith, C. A., Shi, X. & Tahiliani, K. G. (2006). Maternal methyl supplements increase offspring DNA methylation at Axin Fused. Genesis 44, 401-406.
366. Weaver, I. C., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M. & Meaney, M. J. (2004). Epigenetic programming by maternal behavior. Nat Neurosci 7, 847-854.
367. Wei, Y., Mizzen, C. A., Cook, R. G., Gorovsky, M. A. & Allis, C. D. (1998). Phosphorylation of histone H3 at serine 10 is correlated with chromosome condensation during mitosis and meiosis in Tetrahymena. Proc Natl Acad Sci U S A 95, 7480-7484.
368. Weickert, C. S., Hyde, T. M., Lipska, B. K., Herman, M. M., Weinberger, D. R. & Kleinman, J. E. (2003). Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8, 592-610.
369. Weickert, C. S., Ligons, D. L., Romanczyk, T., Ungaro, G., Hyde, T. M., Herman, M. M., Weinberger, D. R. & Kleinman, J. E. (2005). Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry 10, 637-650.
370. Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F. & Goldberg, T. E. (2001). Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50, 825-844.
371. Weksberg, R., Shuman, C., Caluseriu, O., Smith, A. C., Fei, Y. L., Nishikawa, J., Stockley, T. L., Best, L., Chitayat, D., Olney, A., Ives, E., Schneider, A., Bestor, T. H., Li, M., Sadowski, P. & Squire, J. (2002). Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith-Wiedemann syndrome. Hum Mol Genet 11, 1317-1325.
372. Wiedemann, K. (2011). Biomarkers in development of psychotropic drugs. Dialogues Clin Neurosci 13, 225-234.
373. Wilkinson, M. B., Xiao, G., Kumar, A., LaPlant, Q., Renthal, W., Sikder, D., Kodadek, T. J. & Nestler, E. J. (2009). Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J Neurosci 29, 7820-7832.
374. Williams, J., McGuffin, P., Nothen, M. & Owen, M. J. (1997). Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet 349, 1221.
375. Williams, J., Spurlock, G., McGuffin, P., Mallet, J., Nothen, M. M., Gill, M., Aschauer, H., Nylander, P. O., Macciardi, F. & Owen, M. J. (1996). Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet 347, 1294-1296.
376. Woo, T. U., Walsh, J. P. & Benes, F. M. (2004). Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61, 649-657.
377. Woolley, D. W. & Shaw, E. (1954). A biochemical and pharmacological suggestion about certain mental disorders. Proc Natl Acad Sci U S A 40, 228-231.
378. Yasuda, S., Liang, M. H., Marinova, Z., Yahyavi, A. & Chuang, D. M. (2009). The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 14, 51-59.
379. Yoo, A. S. & Crabtree, G. R. (2009). ATP-dependent chromatin remodeling in neural development. Curr Opin Neurobiol 19, 120-126.
380. Yoo, A. S., Staahl, B. T., Chen, L. & Crabtree, G. R. (2009). MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature 460, 642-646.
381. Zahir, F. R. & Brown, C. J. (2011). Epigenetic impacts on neurodevelopment: pathophysiological mechanisms and genetic modes of action. Pediatr Res 69, 92R-100R.
382. Zammit, S., Lewis, S., Gunnell, D. & Smith, G. D. (2007). Schizophrenia and neural tube defects: comparisons from an epidemiological perspective. Schizophr Bull 33, 853-858.
383. Zhang, D., Sliwkowski, M. X., Mark, M., Frantz, G., Akita, R., Sun, Y., Hillan, K., Crowley, C., Brush, J. & Godowski, P. J. (1997). Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci U S A 94, 9562-9567.
384. Zhao, C., Deng, W. & Gage, F. H. (2008). Mechanisms and functional implications of adult neurogenesis. Cell 132, 645-660.
385. Zhao, X., Li, H., Shi, Y., Tang, R., Chen, W., Liu, J., Feng, G., Shi, J., Yan, L., Liu, H. & He, L. (2006). Significant association between the genetic variations in the 5' end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia. Biol Psychiatry 59, 747-753.
386. Zhao, X. D., Han, X., Chew, J. L., Liu, J., Chiu, K. P., Choo, A., Orlov, Y. L., Sung, W. K., Shahab, A., Kuznetsov, V. A., Bourque, G., Oh, S., Ruan, Y., Ng, H. H. & Wei, C. L. (2007). Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 1, 286-298.
387. Zhubi, A., Veldic, M., Puri, N. V., Kadriu, B., Caruncho, H., Loza, I., Sershen, H., Lajtha, A., Smith, R. C., Guidotti, A., Davis, J. M. & Costa, E. (2009). An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes. Schizophr Res 111, 115-122.